ES8707238A1 - Procedimiento para preparar pteridinas - Google Patents

Procedimiento para preparar pteridinas

Info

Publication number
ES8707238A1
ES8707238A1 ES549806A ES549806A ES8707238A1 ES 8707238 A1 ES8707238 A1 ES 8707238A1 ES 549806 A ES549806 A ES 549806A ES 549806 A ES549806 A ES 549806A ES 8707238 A1 ES8707238 A1 ES 8707238A1
Authority
ES
Spain
Prior art keywords
group
denotes
pteridines
piperazino
alkylphenylalkylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES549806A
Other languages
English (en)
Spanish (es)
Other versions
ES549806A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES8707238A1 publication Critical patent/ES8707238A1/es
Publication of ES549806A0 publication Critical patent/ES549806A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES549806A 1984-12-12 1985-12-11 Procedimiento para preparar pteridinas Expired ES8707238A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843445298 DE3445298A1 (de) 1984-12-12 1984-12-12 Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel

Publications (2)

Publication Number Publication Date
ES8707238A1 true ES8707238A1 (es) 1987-07-16
ES549806A0 ES549806A0 (es) 1987-07-16

Family

ID=6252576

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549806A Expired ES8707238A1 (es) 1984-12-12 1985-12-11 Procedimiento para preparar pteridinas

Country Status (15)

Country Link
EP (1) EP0185259A3 (2)
JP (1) JPS61140585A (2)
AU (1) AU576924B2 (2)
CA (1) CA1252783A (2)
DE (1) DE3445298A1 (2)
DK (1) DK161327C (2)
ES (1) ES8707238A1 (2)
FI (1) FI82696C (2)
GR (1) GR852996B (2)
IL (1) IL77294A (2)
NO (1) NO161373C (2)
NZ (1) NZ214522A (2)
PH (1) PH24451A (2)
PT (1) PT81650B (2)
ZA (1) ZA859462B (2)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
EE200400042A (et) 2001-06-28 2004-10-15 Essential Therapeutics, Inc. 8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
EP1658081B1 (en) * 2003-08-29 2007-10-24 4 Aza Ip Nv Immunosuppressive effects of pteridine derivatives
GB2407089A (en) * 2003-10-17 2005-04-20 4 Aza Bioscience Nv Pteridine derivatives
PT1673092E (pt) * 2003-10-17 2007-11-23 4 Aza Ip Nv ''derivados de pteridina substituídos com heterociclos e sua utilização em terapia''
WO2005087227A1 (en) * 2004-03-04 2005-09-22 Neurogen Corporation Arylalkylamino-substituted quinazoline analogues
DE102004057595A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057594A1 (de) * 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substitueirte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057618A1 (de) 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057645A1 (de) * 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
RU2445315C2 (ru) * 2005-11-22 2012-03-20 Кудос Фармасьютиклз Лимитед ПРОИЗВОДНЫЕ ПИРИДО-, ПИРАЗО- И ПИРИМИДО-ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ mTOR
KR101464384B1 (ko) * 2005-11-22 2014-11-21 쿠도스 파마슈티칼스 리미티드 mTOR 억제제로서 피리도피리미딘, 피라조피리미딘 및피리미도피리미딘 유도체
WO2007135026A2 (de) 2006-05-24 2007-11-29 Boehringer Ingelheim International Gmbh Substituierte pteridine als therapeutika
WO2008009078A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
WO2008009079A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
JP5227321B2 (ja) 2006-08-23 2013-07-03 クドス ファーマシューティカルズ リミテッド Mtor阻害剤としての2−メチルモルホリンピリド−、ピラゾ−及びピリミド−ピリミジン誘導体
WO2009153597A2 (en) 2008-06-20 2009-12-23 Astrazeneca Ab Composition and process - 356
SG11201606876RA (en) 2015-03-04 2016-10-28 Gilead Sciences Inc Toll like receptor modulator compounds
SI3507276T1 (sl) 2016-09-02 2022-01-31 Gilead Sciences, Inc. Spojine modulatorja toličnih receptorjev
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159628A (en) * 1962-05-28 1964-12-01 Smith Kline French Lab Pteridine-5-oxide derivatives
DE3323932A1 (de) * 1983-07-02 1985-01-10 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 2-piperazino-pteridine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel

Also Published As

Publication number Publication date
NO854965L (no) 1986-06-13
PT81650A (de) 1986-01-01
EP0185259A3 (de) 1989-03-01
DK161327B (da) 1991-06-24
FI82696B (fi) 1990-12-31
FI854862A0 (fi) 1985-12-10
DK572685A (da) 1986-06-13
CA1252783A (en) 1989-04-18
ES549806A0 (es) 1987-07-16
GR852996B (2) 1986-04-16
NZ214522A (en) 1988-07-28
DK572685D0 (da) 1985-12-11
JPS61140585A (ja) 1986-06-27
FI82696C (fi) 1991-04-10
AU5123285A (en) 1986-06-19
NO161373B (no) 1989-05-02
NO161373C (no) 1989-08-09
PT81650B (pt) 1988-04-21
PH24451A (en) 1990-06-25
DE3445298A1 (de) 1986-06-12
AU576924B2 (en) 1988-09-08
FI854862A7 (fi) 1986-06-13
IL77294A (en) 1989-02-28
DK161327C (da) 1991-12-09
ZA859462B (en) 1987-07-29
EP0185259A2 (de) 1986-06-25

Similar Documents

Publication Publication Date Title
ES8301977A1 (es) Un procedimiento para la preparacion del acido 9-halo-7-oxo-2,3-dihidro-7m-pirido-1,2,3-de-1,4 benzoxazin 6-carboxilico.
ES8703461A1 (es) Procedimiento para preparar derivados de quinuclidina
AU565105B2 (en) Piperazino substituted pteridines
EP0163599A3 (en) Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents
HUT37435A (en) Process for producing thieno/2,3-d/pyrimidine derivatives and salts
AU4174989A (en) Pteridines
ES8700253A1 (es) Procedimiento para preparar compuestos de 5-alquil-1-fenil- -2-piperazinoalquilpirazolin-3-ona
DK120483A (da) Phenylpiperazinderivater og fremgangsmaade til deres fremstilling
YU25684A (en) Process for making new derivatives of pyridine
EP0559116A3 (en) Microbiological process for the hydroxylation of nitrogen containing heterocyclic carbonic acids
ES8301239A1 (es) Procedimiento para la preparacion de nitratos de alquilami- nodesoxi-1.4,3.6-dianhidro-hexito sustituidos con bases pu- rinicas
ES449629A1 (es) Procedimiento para la preparacion de nuevos derivados de benzopiranona.
ES8300116A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
AU571956B2 (en) 3-azinomethyl rifamycins
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
MY101502A (en) Substituted benzymidazole derivatives, process from their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506